​

Vera Therapeutics Ownership | Who Owns Vera Therapeutics?

OverviewForecastFinancialsChart

Vera Therapeutics Ownership Summary

Vera Therapeutics is owned by 109.73% institutional investors, 0.95% insiders. Blackrock funding, inc. /de is the largest institutional shareholder, holding 8.04% of VERA shares. State Street® SPDR® S&P® Biotech ETF is the top mutual fund, with 3.63% of its assets in Vera Therapeutics shares.

VERA Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockVera Therapeutics109.73%0.95%-10.68%
SectorHealthcare Stocks 50.49%12.37%37.14%
IndustryBiotech Stocks 48.95%12.07%38.98%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de5.75M8.04%$246.64M
Avoro capital advisors5.72M8.01%$245.61M
Blackrock3.34M6.55%$120.76M
State street4.15M5.80%$178.02M
Price t rowe associates inc /md/4.01M5.61%$172.20M
Deep track capital, lp4.00M5.60%$171.64M
Vanguard group3.57M5.59%$180.81M
Deerfield management company, l.p. (series c)3.92M5.48%$168.05M
Kynam capital management, lp2.89M4.04%$124.01M
Morgan stanley2.80M3.92%$120.12M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Tri locum partners lp1.19M7.95%$34.59M
Kynam capital management, lp2.89M6.85%$124.01M
Sofinnova investments2.79M6.20%$119.89M
Eversept partners, lp2.21M4.93%$94.95M
Great point partners600.84K4.87%$25.78M
Portman32.80K4.48%$1.19M
Logos global management lp2.20M4.06%$94.40M
Davern capital partners, lp498.83K3.65%$21.40M
Integral health asset management1.75M2.97%$75.09M
Bioimpact capital563.08K2.68%$16.36M

Top Buyers

HolderShares% AssetsChange
Morgan stanley2.80M0.01%2.43M
Logos global management lp2.20M4.06%2.20M
State street4.15M0.01%785.15K
Tri locum partners lp1.19M7.95%777.09K
Frontier capital management1.30M0.52%743.91K

Top Sellers

HolderShares% AssetsChange
T. rowe price investment management---1.68M
Paradigm biocapital advisors lp---1.44M
Vestal point capital, lp---1.37M
Holocene advisors, lp---1.31M
Point72 asset management40.56K0.00%-1.17M

New Positions

HolderShares% AssetsChangeValue
Logos global management lp2.20M4.06%2.20M$94.40M
Sixth street partners management company545.01K0.00%545.01K$23.39M
Davern capital partners, lp498.83K3.65%498.83K$21.40M
Hsbc297.02K0.00%297.02K$8.63M
Readystate asset management lp295.11K0.43%295.11K$12.66M

Sold Out

HolderChange
Ifp advisors-1.00
True wealth design-1.00
Twin peaks wealth advisors-2.00
Massmutual trust co fsb/adv-3.00
Coldstream capital management-6.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2026231-2.94%78,430,7408.58%1091.07%131-7.09%673.08%
Mar 31, 20262376.28%72,234,406-2.40%1120.84%140-2.78%658.33%
Dec 31, 2025146-19.34%42,673,172-34.42%660.64%91-9.90%42-12.50%
Sep 30, 2025175-0.57%63,626,8635.34%991.11%96-6.80%46-2.13%
Jun 30, 20251840.55%63,880,1552.67%1001.05%1089.09%47-4.08%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
State Street® SPDR® S&P® Biotech ETF2.60M3.63%5.98K
Vanguard Morn Total Stk Mkt Idx Investor1.93M2.70%22.57K
Vanguard Total Stock Mkt Idx Inv1.93M2.70%22.57K
Vanguard MStar Total Stk Mkt Idx Invest1.94M2.70%8.94K
iShares Russell 2000 ETF1.63M2.27%-28.90K
Fidelity Growth Compy Commingled Pl O1.16M2.11%-
Vanguard US Total Market Shares ETF1.33M2.09%-2.90K
Fidelity Growth Compy Commingled Pl S1.20M1.68%-
US Small-Cap Growth II Equity Comp1.01M1.41%-109.49K
T. Rowe Price New Horizons1.01M1.41%-75.80K

Recent Insider Transactions

DateNameRoleActivityValue
Jul 07, 2026Fordyce Marshall PRESIDENT AND CEOSell$450.01K
Jul 07, 2026Fordyce Marshall PRESIDENT AND CEOSell$95.91K
Jul 07, 2026Fordyce Marshall PRESIDENT AND CEOSell$40.78K
Jul 07, 2026Fordyce Marshall PRESIDENT AND CEOSell$1.37M
Jun 23, 2026Fordyce Marshall PRESIDENT AND CEOSell$698.39K

Insider Transactions Trends

DateBuySell
2026 Q3-4
2026 Q2-7
2026 Q1-7
2025 Q415
2025 Q24-

VERA Ownership FAQ

Who Owns Vera Therapeutics?

Vera Therapeutics shareholders are primarily institutional investors at 109.73%, followed by 0.95% insiders and -10.68% retail investors. The average institutional ownership in Vera Therapeutics's industry, Biotech Stocks , is 48.95%, which Vera Therapeutics exceeds.

Who owns the most shares of Vera Therapeutics?

Vera Therapeutics’s largest shareholders are Blackrock funding, inc. /de (5.75M shares, 8.04%), Avoro capital advisors (5.72M shares, 8.01%), and Blackrock (3.34M shares, 6.55%). Together, they hold 22.60% of Vera Therapeutics’s total shares outstanding.

Does Blackrock own Vera Therapeutics?

Yes, BlackRock owns 6.55% of Vera Therapeutics, totaling 3.34M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 120.76M$. In the last quarter, BlackRock increased its holdings by 18.71K shares, a 0.56% change.

Who is Vera Therapeutics’s biggest shareholder by percentage of total assets invested?

Tri locum partners lp is Vera Therapeutics’s biggest shareholder by percentage of total assets invested, with 7.95% of its assets in 1.19M Vera Therapeutics shares, valued at 34.59M$.

Who is the top mutual fund holder of Vera Therapeutics shares?

State Street® SPDR® S&P® Biotech ETF is the top mutual fund holder of Vera Therapeutics shares, with 3.63% of its total shares outstanding invested in 2.6M Vera Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools